Repurposed Antiparasitic Drugs in Oncology: A Landscape Overview
Repurposed Antiparasitic Drugs in Oncology: A Landscape Overview Drug repurposing — the application of existing approved compounds to new therapeutic
March 8, 2026 No Comments
Repurposed Antiparasitic Drugs in Oncology: A Landscape Overview Drug repurposing — the application of existing approved compounds to new therapeutic
Fenbendazole and Breast Cancer: Emerging Research on Cell Growth Pathways Fenbendazole, a benzimidazole anthelmintic long used in veterinary medicine, has
Combining Fenbendazole with Conventional Chemotherapy: Preclinical Insights The concept of combining fenbendazole with established chemotherapy agents has attracted increasing attention
Ivermectin’s Anti-Cancer Mechanisms: From Autophagy to Tumor Microenvironment Ivermectin is an FDA-approved macrocyclic lactone antiparasitic that has been used safely
Fenbendazole and Colorectal Cancer: What Laboratory Evidence Reveals Fenbendazole is a benzimidazole anthelmintic compound that has attracted growing attention in
Fenbendazole absorption plays a central role in how the compound behaves in off-label protocols. Fenbendazole has very low water solubility
Interest in drug repurposing for cancer research continues to grow. One compound drawing attention is Fenbendazole (FBZ), a medication long
Thyroid cancer represents the most common endocrine malignancy worldwide. Among its subtypes, papillary thyroid cancer (PTC) accounts for roughly 80%
Fenben Lab, a well-established name in the Fenbendazole market, claims high product quality. However, our investigation reveals concerning practices, including